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INTRODUCTION
Patients with nasal polyps often suffer from progressive nasal 
congestion, hyposmia, and rhinorrhea, which are frequently 
confused with symptoms of allergic rhinitis and chronic sinus-
itis.1-3 This is especially the case in a patient with chronic rhino-
sinusitis with nasal polyps (CRSwNP), who suffers from pro-
longed rhinorrhea even after adequate antimicrobial treatment. 
CRSwNP is a disorder characterized by persistent eosinophil-
ic Th2 inflammation and frequent sinonasal microbial coloni-
zation.4 Studies of cytokines associated with chronic rhinosi-
nusitis have showed that CRSwNP or CRS without nasal polyps 
(CRSsNP) have a mixed Th1/Th2 cytokine profile, indicating 
that cytokines play an important pathologic role in these condi-
tions.4-11 A recent study investigating the expression of various 
cytokines in nasal epithelial cell cultures of CRSwNP or CRSs-
NP patients and controls has demonstrated that IL-4 and IL-13 
are increased in CRSwNP, whereas IL-4 is increased in CRSsNP, 
compared to controls.5 Ramanathan et al.4 created a model of 
the Th2 inflammatory environment based on exposure of pri-
mary human sinonasal epithelial cells (HSNECs) to the Th2 cy-
tokines interleukin IL-4 or IL-13 for 36 hours  and demonstrat-
ed that treatment of HSNECs with IL-4 or IL-13 significantly 
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down-regulates the baseline expression of antimicrobial innate 
immune genes and leads to microbial colonization and abnor-
mal immune responses associated with CRSwNP. Another re-
cent study compared the levels of eosinophil chemoattractant 
cytokines in nasal lavage fluid and nasal polyp tissue extracts 
from CRSwNP patients and showed that IL-5 and IL-13 and 
RANTES are elevated in parallel in nasal lavage fluid and nasal 
polyps from these patients.9 Furthermore, IL-13 is also elevated 
in nasal polyp compared to control uncinate processes (UP) 
and CRSsNP UP.9 Similarly, the serum levels of IL-13 have also 
been shown to be significantly higher in patients with CRSwNP 
than in healthy controls,10 and coincide with significantly high-
er levels of total IgE in patients with CRSwNP, possibly predis-
posing them to concomitant asthma.10,11
Increasing evidence suggests that calcium-activated chloride 
channels (CaCCs) play an important role in transepithelial 
transport and mucus overproduction in the airway epitheli-
um.12,13 Although the molecular identity of CaCCs is not entirely 
clear, several membrane proteins, such as calcium-activated 
chloride channel protein (CLCA),14 Bestrophins,15,16 and Tweety,17 
have been postulated as candidates. However, electrophysiolog-
ical characterization of these candidate channels has indicated 
that Cl- currents and Ca2+-mediated current-voltage relation-
ships for these channels are actually different from those of clas-
sical CaCCs.18 More recently, using different approaches, 3 labo-
ratories have simultaneously reported that the molecule trans-
membrane protein 16A (TMEM16A) is a strong candidate for 
CaCCs.19-21 These studies demonstrated that the expression of 
TMEM16A in different cell systems (HEK-293 and FRT cells, and 
Axolotl oocytes) consistently leads to the appearance of voltage-
dependent Ca2+-activated Cl- channel, namely, classical 
CaCCs.19-21 Indeed, while Yang et al.20 have shown TMEM16A to 
be a bona fide Ca2+-activated chloride channel that is activated 
by intracellular Ca2+ and Ca2+-mobilizing stimuli, Caputo et al.,21 
using global gene expression analysis to identify IL-4-regulated 
CaCC membrane proteins, have shown TMEM16A to be an in-
trinsic constituent of the calcium-dependent chloride channel. 
It has been demonstrated that TMEM16A plays an important 
role in the regulation of airway fluid and electrolyte transport in 
airway epithelial cells22 and that TMEM16A knockout mice die 
soon after birth because of significant mucus accumulation in 
the trachea and tracheomalacia.23
Very few studies have been performed to investigate the role 
of TMEM16A in mucin secretion. In the lower airways, benz-
bromarone, as a TMEM16A inhibitor of high-throughput screen-
ing, blocks ATP-induced CaCC current and prevents ATP-in-
duced mucin secretion by MUC5AC staining of the mucin 
stores in normal human bronchial epithelial cells treated with 
IL-13.24 However, the expression of TMEM16A in nasal polyp 
tissue and the role of TMEM16A in mucin secretion from nasal 
polyp epithelial cells induced by IL-13 remain unknown. 
Meanwhile, the role of T16Ainh-A01 as a TMEM16A inhibitor 
in airways seems to be a matter of debate. Though T16Ainh-
A01 causes only partial inhibition of Cl- secretion triggered by 
Ca2+-elevating agents in human bronchial and intestinal cells, 
T16Ainh-A01-sensitive current is increased by 8-fold in IL-
4-treated cystic fibrosis human bronchial epithelial cells com-
pared to untreated cells.25 Thus, it is possible that T16Ainh-A01 
could have a stronger inhibitory effect on CaCC activity in a Th2 
inflammatory environment. The aims of this study were to in-
vestigate the expressions of TMEM16A and MUC5AC in nasal 
polyp tissue and to determine whether TMEM16A could regu-
late mucin secretion by cultured human nasal polyp epithelial 
cells (HNPECs) induced by IL-13. This study also aimed to de-
termine if TMEM16A-induced effects in HNPECs could be in-
hibited by T16Ainh-A01.
 
MATERIALS AND METHODS
Patients
Twenty patients with CRSwNP and 10 control subjects were 
enrolled in the study from the Rhinology ward, Department of 
Otolaryngology, Head and Neck Surgery, Beijing TongRen Hos-
pital. The diagnosis of CRSwNP was made according to the cur-
rent European EAACI Position Paper on Rhinosinusitis and Na-
sal Polyps.26 Comprehensive clinical characterics, including na-
sal symptoms, examination, nasal endoscopy, and computed 
tomographic scanning of the sinus were made for diagnostic 
evaluation of each patient. All CRSwNP patients had at least 1 
sinonasal polyp, as determined by nasal endoscopy before or at 
the time of endoscopic sinus surgery, and any patient who had 
received systemic pharmacotherapy for sinusitis, such as mac-
rolide antibiotics or intranasal glucocorticoids, for a period of at 
least 4 weeks prior to surgery was excluded. Ten adult patients 
who had maxillary sinus cyst, cerebrospinal fluid rhinorrhea 
without acute rhinosinusitis, CRSsNP, or allergic rhinitis, were 
enrolled as control subjects. The atopic status of each patient 
was evaluated by skin prick tests (SPT), using a standard panel 
of 20 common regional inhalant allergens. Six of the patients 
with CRSwNP were SPT-positive, and all the control subjects 
were SPT-negative.
The study protocol was reviewed and approved by the local 
ethics board of Beijing TongRen Hospital, Capital Medical Uni-
versity, and the study was performed at the Department of Oto-
laryngology, Head and Neck Surgery, Beijing TongRen Hospi-
tal. Written informed consent was obtained from all subjects 
prior to their participation in the study.
Cell culture
Epithelial cell dissociation from human sinus mucosal tissues
Human nasal polyps from CRSwNP patients and normal si-
nonasal mucosa tissues from control subjects were obtained 
during endoscopic sinus surgery, and immediately placed in 
sterile cold saline. All samples were washed with D-hanks bal-
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anced salt solutions supplemented by penicillin (100 U/mL; 
Gibco, Carlsbad, CA, USA), streptomycin (100 µg/mL; Gibco), 
amphotericin B (2.5 µg/mL; Gibco) and  incubated in 0.5% pro-
tease (type XIV; Sigma, St.Louis, MO, USA) in Dulbecco’s Modi-
fied Eagle’s Medium (DMEM; Gibco) overnight at 4˚C. Follow-
ing incubation, the protease was neutralized with an equal vol-
ume of DMEM containing 10% bovine serum, and the epitheli-
al cells were released from the tissues by vigorous shaking. The 
cells were harvested after centrifugation and resuspension in 
fresh DMEM and plated on a plastic dish at 37˚C for 1 hour to 
eliminate fibroblasts, endothelial cells, and myoblasts.
Culture of sinonasal epithelial cells as air-liquid interface cultures 
(ALI)
The dissociated epithelial cells were seeded into collagen-
coated 100-mm tissue culture dishes and cultured in serum-
free bronchial epithelial growth medium (BEGM) at 37˚C in an 
atmosphere of 5% CO2 and 95% relative humidity. The culture 
medium was changed every 2 days; when the cultures reached 
70%-80% confluence, the cells were detached with 0.05% tryp-
sin-EDTA (Gibco). The detached cells were washed with fresh 
medium and then seeded on 6- or 24-well BD falcon cell cul-
ture inserts (23.1 mm or 6.4mm, polyester 0.4 µm, Becton Dick-
inson Corp [BD], Bedford, MA, USA) at a density of 2×105 
cells/cm2. Both sides of the Transwell were filled with BEGM: 
DMEM (50:50); supplemented with hydrocortisone (0.5 µg/
mL), insulin (5 µg/mL), transferrin (10 µg/mL), epinephrine 
(0.5 µg/mL), triiodothyronine (6.5 µg/mL), gentamycin (50 µg/
mL), retinoic acid (0.1 ng/mL), and epidermal growth factor 
(0.5 ng/mL human recombinant) (all supplied by Clonetics 
Corp, San Diego, CA, USA); and culture as above. On reaching 
confluence, the apical medium was removed and cells were 
cultured further at an air-liquid interface at 37˚C in an atmo-
sphere of 5% CO2 and 95% relative humidity.
Effect of treatment with IL-13 and TMEM16A inhibitor
Medium containing IL-13 (10 ng/mL; PeproTech, Rocky Hill, 
NJ, USA) was added to the basolateral side of the inserts from 
beginning of ALI culture for 14 days as described before.27,28 Like-
wise, medium containing T16Ainh-A01 (10 µM; Tocris, Bristol, 
UK), a TMEM16A inhibitor, was added in the same manner. 
Control wells were cultured with 0.5 mL of ALI medium alone.  
 
Immunohistochemistry 
Freshly obtained sinonasal mucosal tissues from control sub-
jects and patients with CRSwNP were assessed for the presence 
of TMEM16 A and MUC5A by immunohistochemistry. Briefly, 
all samples were fixed with 10% paraformaldehyde (pH 7.4), 
embedded in paraffin, and cut into 4-µm thick sections. After 
autoclave pretreatment, the sections were incubated with 3% 
hydrogen peroxide, rinsed in phosphate buffered solution 
(PBS), and blocked with 5% skimmed milk, prior to being incu-
bated overnight at 4˚C with TMEM16A antibody (rabbit mono-
clonal; 1:100; Abcam, Cambridge, MA, USA) or MUC5AC anti-
body (mouse monoclonal; 1:100; Sigma). The sections were 
subsequently incubated with peroxidise- conjugated second-
ary antibody for 40 minutes at 37˚C, and at the end of incuba-
tion the peroxidase activity was visualized by a colour reaction 
using diaminobenzidine (DAB) as the substrate. The slides 
were counterstained with haematoxylin, mounted, and exam-
ined using an Olympus BX51 microscope (Tokyo, Japan).
Immunofluorescence
ALI-cultured HNPECs were assessed for the presence of 
TMEM16 A and MUC5A by immunofluorescence. Briefly, the 
cultures were fixed in a 50:50 mixture of methanol-acetone, 
rinsed in PBS, treated with 0.3% triton X-100, and then blocked 
with 5% skimmed milk prior to being incubated overnight at 
4˚C with TMEM16A antibody (rabbit monoclonal; 1:200; Ab-
cam) and MUC5AC antibody (mouse monoclonal; 1:100; Sig-
ma) or acetylated-tubulin antibody (mouse monoclonal; 1:800; 
Sigma). At the end of this incubation the cells were further in-
cubated with the secondary antibody (fluorescein isothiocya-
nate-conjugated goat anti-rabbit IgG; 1:100 and rhodamine-
conjugated goat anti-mouse IgG; 1:100) for 90 minutes at 37˚C, 
and then counterstained with DAPI nuclear stain. The stained 
cells were examined using an Olympus IX81 confocal micro-
scope, and image analysis was performed using the Image J 
software. TMEM16A-positive cells, cells expressing both TME-
M16A and MUC5AC, and total number of cells (nuclei) were 
counted manually inXY fields of 300×300 µm, and the TME-
M16A-positive and TMEM16A+MUC5AC-positive cells were 
expressed as the percentages of total cells.
Western blotting
Sinonasal epithelial or primary cell lysates containing equal 
amounts of proteins were loaded in separate lanes on a 8% SDS-
PAGE gel. After separation, the proteins were transferred onto 
nitrocellulose membrane, and nonspecific binding sites were 
blocked by treating with 5% non-fat dry milk powder. The mem-
branes were then treated with primary antibodies directed 
against TMEM16A (rabbit monoclonal, 1:1,000; Abcam), fol-
lowed by treatment with secondary HRP-conjugated anti-rabbit 
(1:20,000) for 1 hour at room temperature. Secondary antibody-
bound protein was detected using the Millipore ECL kit. To con-
firm equal protein loading, blots were reprobed with β-actin an-
tibody (1:5,000). Data were analyzed using the Image J software.
MUC5AC ELISA
The nasal tissue was processed according to methods as de-
scribed previously.29 Briefly, snap frozen tissues were weighed, 
and 1 mL of 0.9% NaCl solution was added per 0.1 g of tissue. 
The tissue was homogenized with a mechanical homogenizer 
(Kinematica, Lucerne, Switzerland) at 1,000 rpm for 5 minutes 
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on ice, and the suspension was centrifuged at 3,000 rpm for 10 
minutes at 4˚C. The supernatants were separated and stored at 
-80˚C until analysis for MUC5AC using commercial ELISA kits 
(BlueGene Biotech, Shanghai, China) according to the manu-
facturer’s instruction. 
Similarly, ALI-cultured cells were washed 5 times with PBS 
before being exposed to any stimulation. After different stimu-
lation, apical washings (200 µL of PBS/well, 5 times) were col-
lected and  centrifuged at 2,000 rpm for 5 minutes at 4˚C. The 
supernatants were collected and stored at -80˚C until assay for 
MUC5AC as above.
Statistical analysis
Statistical analysis was performed using the SPSS17.0 software 
(SPSS, Inc., Chicago, IL, USA). Data were not available for some 
assays because of the limited amount of samples obtained at 
surgery. Data for all assessed samples are expressed as mean± 
SEM, and any significance of differences between grouped data 
was calculated using Student’s paired t test (two-tailed) or one-
way analysis of variance (ANOVA) with post hoc Dunnett’s test. 
A P value of <0.05 was considered significant.
RESULTS
Expressions of TMEM16A and MUC5AC in human sinonasal 
mucosa tissue and dissociated human sinonasal epithelium
Immunohistochemical staining showed that TMEM16A and 
MUC5AC proteins were stained strongly in the CRSwNP group 
(Fig. 1A and B). TMEM16A was expressed throughout the nasal 
polyp epithelium (the apical side, intracytoplasm, and basolat-
eral side), whereas MUC5A was mostly expressed on the apical 
side of the nasal polyp epithelium. In contrast, relatively weak 
expressions of TMEM16A and MUC5AC were noted in normal 
sinonasal epithelium (Fig. 1C and D). Densitometric analysis of 
TMEM16A (114 kDa) bands revealed a 4.4-fold increase (Fig. 
2A and B), and MUC5AC measured by ELISA was also signifi-
cantly increased by 6-fold (Fig. 2C) in dissociated human nasal 
polyp epithelium compared to normal sinonasal epithelium.
Location of TMEM16A and MUC5AC in ALI-cultured HNPECs
To further investigate the localization of TMEM16A and MU-
Fig. 1. Immunohistochemical staining for TMEM16A and MUC5AC in human 
sinonasal epithelium: TMEM16A and MUC5AC proteins in human nasal polyp 
epithelium (HNPE group) (A, B) and normal sinonasal epithelium (control group) 
(C, D). Tissues were stained with anti-TMEM16A (1:200) and anti-MUC5AC 
(1:500). Arrowheads show TMEM16A-positive cells, and arrows show MU-
C5AC-positive cells. The images were observed with a 40× objective.
A
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42 kDa
Control HNPE
β-actin
Fig. 2. Expressions of TMEM16A and MUC5AC proteins in dissociated human 
sinonasal epithelium. (A) The expression of TMEM16A protein was detected by 
Western blotting in dissociated normal sinonasal epithelium (control group) and 
nasal polyp epithelium (HNPE group). (B) Comparison of the expression of TME-
M16A protein by densitometric analysis between the control and HNPE groups. 
Each bar represents the relative density of TMEM16A band normalized to 
β-actin band for each sample (n=6, ***P<0.001). (C) Measurement of MU-
C5AC by ELISA from supernatants of nasal tissue homogenate in control and 
HNPE groups (n=6, ***P<0.001). 
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C5AC further, we performed immunofluorescence combined 
with confocal microscopy to assess the expressions of TME-
M16A, MUC5AC, and acetylated-tubulin protein (a marker for 
ciliated cells) in ALI-cultured HNPECs incubated with or with-
out IL-13 (10 ng/mL) for 14 days.  TMEM16A expression was 
mainly expressed in MUC5AC-positive cells in cultured 
HNPECs incubated with IL-13, with a weak expression noted in 
the control group. MUC5AC protein was localized in mucus 
granules, and TMEM16A protein was localized on the circum-
ference of the MUC5AC protein (Fig. 3A and B). TMEM16A and 
Fig. 4. Expression of TMEM16A in non-ciliated cells. Confocal microscopy xy images of ALI-cultured HNPECs without IL-13 (A) and with IL-13 (10 ng/mL, 14 days) (B) 
showing immunoreactivity for TMEM16A (red) and acetylated-tubulin (green). Nuclei stained with DAPI appear blue. The 2 images show that TMEM16A and acety-
lated-tubulin staining appears on different epithelial cells. The images were taken with a 40× objective. Scale bars: 50 µm.
Fig. 3. Coexpression of TMEM16A and MUC5AC in ALI-cultured HNPECs. Confocal microscopy xy images of ALI-cultured HNPECs without IL-13  (A) and with IL-13 
treatment (10 ng/mL, 14 days) (B) showing over lapping immunoreactivity for TMEM16A (red) and MUC5AC (green). Nuclei stained with DAPI appear blue.  The im-
ages were taken with a 40× objective. Scale bars: 50 µm.
A
A
B
B
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acetylated-tubulin proteins were not coexpressed within the 
same cells in HNPECs incubated with or without IL-13, indicat-
ing that TMEM16A was not expressed on ciliated cells (Fig. 4A 
and B).
Effect of IL-13 on the expression of TMEM16A and the 
secretion of MUC5AC in ALI-cultured HNPECs
The percentage of TMEM16A-positive cells and MUC5AC-
positive cells was significantly higher in HNPECs incubated 
with IL-13 10 ng/mL for 14 days (23.0%±2.5% and 21.9%±6.0% 
of total cells, respectively) than in those which was not (4.4%±
0.7% and 3.9%±1.5% of total cells, respectively; both P<0.001). 
Similarly, incubation of cells from control subjects with IL-13 
significantly increased the percentage of TMEM16A-positive 
cells from 3.8%±0.4% to 25.8%±2.1% of total cells (n=6, 
P<0.001) and MUC5AC-positive cells from 3.5%±1.0% to 
24.8%±5.0% (n=6, P<0.001). There was no significant differ-
ence in the proportion of TMEM16A-positive and MUC5AC-
positive cells between cells of control subjects and the  HNPECs 
group incubated with IL-13 for 14 days (n=6). The proportions 
of coexpressing TMEM16A and MUC5AC cells incubated with 
IL-13 in  HNPECs (18.6%±1.6%)  and epithelial cells from con-
trol subjects (21.2%±1.2%) were significantly higher compared 
than  those which were not (n=6, P<0.001) (Fig. 5A). In the 2 
groups of cultures incubated with IL-13, the percentage of 
TMEM16A-positive cells also expressing MUC5AC reached 
more than 80% of those expressing TMEM16A, respectively. 
We further examined the expression of TMEM16A in cell ly-
sates by Western blot analysis and MUC5AC secretion in apical 
washings of cells by ELISA. Densitometric analysis of TME-
M16A bands revealed an approximately 3-fold increase (Fig. 5B 
and C) and MUC5AC was also increased by approximately 
5-fold (Fig. 5D) in the 2 groups incubated with IL-13 compared 
to the corresponding control groups incubated without IL-13. 
There was no significant difference in the expressions of the 2 
proteins in epithelial cells from control subjects and patients 
with CRSwNP incubated with IL-13 for 14 days (n=6). 
Effect of TMEM16A inhibitor on the expression of TMEM16A 
and the secretion of MUC5AC in HNPECs induced with IL-13
The effect of inhibition of TMEM16A on the expression of 
TMEM16A and the secretion of MUC5AC induced by IL-13 (10 
ng/mL for 14 days) in ALI culture was investigated by incubating 
the cells with T16Ainh-A01 (10 µM for 14 days). The percentage 
Fig. 5. Increased expression of TMEM16A and secretion of MUC5AC in ALI-cultured HNPECs with IL-13. (A) The percentage of TMEM16A-positive cells, MUC5AC-
positive  cells, and cells coexpressing MUC5AC and TMEM16A in ALI-cultured HSNECs (control group) and HNPECs incubated with or without IL-13 (10 ng/ml) for 
14 days (n=6, ***P<0.001). (B) Detection of TMEM16A protein by Western blot in lysates from HNPECs and control cells incubated with or without IL-13 (10 ng/
mL) for 14 days. (C) Comparison of the expression of TMEM16A protein by densitometric analysis. Each bar reports the relative density of TMEM16A band normal-
ized to β-actin band for each sample (n=6, ***P<0.001). (D) Detection of MUC5AC by ELISA in apical washings from HNPECs and control cells incubated with or 
without IL-13 (10 ng/mL) for 14 days (n=6, ***P<0.001).
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of TMEM16A-positive cells was significantly decreased from 
23.5%±3.4% to 6.1%±1.6% of total cells, and the percentage of 
MUC5AC-positive cells was decreased from 27.3%±6.9% to 
7.6%±2.1% of total cells in HNPECs incubated with IL-13 in the 
presence of T16Ainh-A01 (n=6, both P<0.001); consequently, 
the percentage of cell co-expressing TMEM16A and MUC5AC 
was significantly decreased from 19.1%±1.6% to 2.0%±0.7% of 
total cells (n=6, P<0.001). T16Ainh-A01 did not significantly de-
crease the percentage of TMEM16A-positive cells, MUC5AC-
positive cells, and cells coexpressing TMEM16A and MUC5AC 
in HNPECs incubated without IL-13 (Fig. 6A). As shown in (Fig. 
6B-D), TMEM16A and MUC5AC protein levels were significant-
ly lower in HNPECs incubated with T16Ainh-A01 plus IL-13 
than in those incubated with IL-13 alone. A T16Ainh-A01-in-
duced 68% decrease (P<0.001) in the TMEM16A level was not-
ed in HNPECs incubated with IL-13. Likewise, addition of 
T16Ainh-A01 significantly decreased MUC5AC secretion by 
46.2% (P<0.01) in HNPECs incubated with IL-13.
DISCUSSION
In this study, we for the first time reported on the relationship 
between TMEM16A and MUC5AC secretion in CRSwNP in a 
Th2 inflammatory condition model. Our study demonstrated 
that the expressions of TMEM16A and MUC5AC were in-
creased in sinonasal mucosa tissue and dissociated sinonasal 
epithelium from patients with CRSwNP, compared to subjects 
not suffering from CRS. TMEM16A was detected mainly in MU-
C5AC-positive cells in HNPECs induced by IL-13. IL-13 treat-
ment also significantly increased the percentage of TMEM16A-
positive cells, the percentage of MUC5AC-positive cells, the 
percentage of cells coexpressing TMEM16A and MUC5AC, the 
expression of TMEM16A protein, and the secretion of MUC5AC 
in ALI-cultured sinonasal epithelial cells from control subjects 
and patients with CRSwNP. Treatment of these cells with 
T16Ainh-A01, a TMEM16A inhibitor, attenuated the IL-13-in-
duced increases in TMEM16A-positive cells, MUC5AC-positive 
cells, cells coexpressing TMEM16A and MUC5AC, the expres-
sion of TMEM16A, and the secretion of MUC5AC in HNPECs. 
A previous study employing an asthmatic mouse model has 
demonstrated that in airway epithelial cells, TMEM16A is 
strongly expressed in apical membranes of MUC5AC-positive 
mucosal cells.24 Another previous study has suggested that 
TMEM16A is expressed in precursors of goblet cells of bronchi-
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M16A-positive cells, MUC5AC-positive cells, and cells coexpressing MUC5AC and TMEM16A in ALI-cultured HNPECs incubated with or without IL-13 (10 ng/mL) + 
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al epithelial cells, which may be derived from Clara cells.30 By 
immunohistochemical analysis, we found that TMEM16A was 
present not only in the apical cell membrane and on the cir-
cumference of MUC5AC protein but also on the basolateral 
side of nasal polyp epithelium. This finding suggests that in 
CRSwNP, basal epithelial cells may also easily differentiate into 
TMEM16A-positive cells. By immunofluorescence staining, our 
study further indicated that TMEM16A was mainly distributed 
in most of the MUC5AC-positive cells in HNPECs, but not in 
ciliated cells and that TMEM16A protein gathered around mu-
cin granules. The finding of the presence of TMEM16A in both 
the cell membrane and the cytoplasm raises the possibility that 
TMEM16A could be involved in the transport of intracellular 
mucin and extracellular mucin secretion.
So far, studies on the role of TMEM16A in mucus secretion 
have mainly focused on hydration of mucus, involving the rela-
tionship between Cl- secretion and viscous/elastic properties of 
mucus. Although TMEM16A has been reported as a minor 
component of calcium-activated chloride channel conduc-
tance in airway and intestinal epithelial cells,25 a recent study in 
mice lacking the expression of TMEM16A (Tmem16a(-/-) 
mice) has  demonstrated a defect in Ca2+-dependent Cl- secre-
tion in native epithelia of these mice.31 Similarly, Ca2+-depen-
dent Cl- transport is missing or largely reduced in isolated tra-
cheal and colonic epithelia, and measurements of particle 
transport on the surface of tracheas ex vivo indicate largely re-
duced mucociliary clearance.31 Rock et al.23 have suggested that 
in Tmem16a(-/-) mice, TMEM16A-mediated Cl- secretion may 
be necessary for normal airway surface liquid homeostasis. 
They also stated that in trachea of these mice, there was a >60% 
reduction in purinoceptor (UTP)-regulated CaCC activity and 
that the residual CaCC activity appeared inadequate for normal 
airway hydration because Tmem16a(-/-) tracheas exhibited 
significant, neonatal, luminal mucus accumulation. Calcium-
dependent chloride channel activity has also been shown to be 
increased by the treatment of bronchial epithelial cells with in-
terleukin-4 (IL-4).21 Addition of UTP increases currents due to 
Cl- secretion. However, UTP-dependent Cl- currents are signifi-
cantly reduced in cells transfected with anti-TMEM16A siRNA, 
with or without IL-4 treatment.21 Collectively, those studies 
have documented that TMEM16A plays an important role in 
the hydration of mucus, particularly by Cl- ion transport. 
To date, little information is available on the effects of TME-
M16A on the production and secretion of mucin in a Th2 in-
flammatory environment. Our study showed that the expres-
sions of TMEM16A and MUC5AC proteins were significantly 
increased, as indicated by Western blot analysis and ELISA, in 
dissociated nasal polyp epithelium ex vivo and in ALI-cultured 
sinonasal epithelial cells from control subjects and patients 
with CRSwNP, after exposure to IL-13. Some researchers have 
reported that IL-13 can increase goblet cell density and that the 
elimination of IL-13 reverses the established goblet cell meta-
plasia into ciliated cells in airway epithelial cell culture.32 We 
found that the expressions of TMEM16A and MUC5AC were 
closely related to epithelial cell differentiation and that the lack 
of IL-13, i.e., elimination of the Th2 inflammatory environment, 
resulted in weak expressions of these proteins in ALI-cultured 
sinonasal epithelial cells. A previous study has shown that ni-
flumic acid, a blocker of calcium-activated chloride channel 
(CLCA, former CaCC), effectively suppresses goblet cell hyper-
plasia, eosinophilic infiltration, and the expression of MUC5AC 
gene after  instillation of IL-13 into mice airways, via the JAK2/
STAT6 pathway.33 Although TMEM16A has drawn more atten-
tion as a CaCC, whether it involves mucin secretion in upper 
chronic inflammatory airways has not been investigated. A re-
cent study has shown that IL-13 dramatically increases CaCC 
currents, as measured by the short circuit current (Isc) in the 
Ussing chamber, and TMEM16A mRNA in human bronchial 
epithelial cells.24 Our data suggest that T16Ainh-A01, a TME-
M16A inhibitor, may suppress goblet cell differentiation in-
duced by IL-13, decreasing the percentage of TMEM16A posi-
tive cells, the percentage of MUC5AC-positive cells, the per-
centage of cells coexpressing TMEM16A and MUC5AC, with 
subsequent reduction in the expression of TMEM16A protein 
and the secretion of MUC5AC. However, T16Ainh-A01 has no 
effect on mucin secretion in inactivated HNPECs in the ab-
sence of IL-13. 
In summary, IL-13 increased the percentages of TMEM16A-
positive cells, MUC5AC-positive cells, and cells coexpressing 
TMEM16A and MUC5AC, the expression of TMEM16A protein, 
and the secretion of MUC5ACin HNPECs. This study suggests 
that TMEM16A may play an important role in the modulation 
of mucin secretion in HNPECs induced by IL-13, and provide 
an insight into novel ways to improve abnormal mucus secre-
tion in CRSwNP or other nasal inflammatory diseases associat-
ed with Th2 cytokines. However, as mucin secretion is a com-
plex and delicate process, involving mucin granule production, 
movement of granules, fusion of granules and membrane, and 
opening of the granule with release of mucin onto the surface 
of the airways,34 future studies need to focus on molecular 
mechanisms underlying the role of TMEM16A in mucin pro-
duction and secretion from airway epithelial cells induced by 
Th2 cytokines.
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